Search
Palivizumab
go.drugbank.com/drugs/DB00110ApprovedInvestigationalHumanized monoclonal antibody (IgG1k) produced by recombinant DNA technology, directed to an epitope in the A antigenic site of the F protein of respiratory syncytial virus (RSV).
Categories: Antiinfectives for Systemic UseProducts: Synagis 100mg/ml solution for Injection, SYNAGIS SOLUTION FOR INJECTION 100MG/MLCotton seed
go.drugbank.com/drugs/DB10408ApprovedCotton seed allergenic extract is used in allergenic testing.
Products: Cotton Seed for Diagnostic Use OnlyMusca domestica
go.drugbank.com/drugs/DB10688ApprovedHousefly allergenic extract is used in allergenic testing.
Products: Housefly for Diagnostic Use OnlyHuman Rho(D) immune globulin
go.drugbank.com/drugs/DB11597ApprovedIt was approved by FDA as treatment for suppression of rhesus (Rh) isoimmunization or chronic immune thrombocytopenic purpura (ITP) in adults.
Categories: Antiinfectives for Systemic UseProducts: RHESONATIV 625 IU/ML SOLUTION FOR INJECTION, rhophylac 300 microgram/2ml,solution for injection in pre-filled syringeBromhexine
go.drugbank.com/drugs/DB09019ApprovedInvestigationalIt was introduced into the market in 1963, and is widely available as an over-the-counter drug in many countries. … Bromhexine is mucolytic agent used for a variety of respiratory conditions associated with increased mucus secretion.
Mixtures: BODREX FLU & BATUK BERDAHAK PEProducts: BROMHEXIN K M HUS 8MG/10ML, HUSTAB PElranatamab
go.drugbank.com/drugs/DB15395ApprovedInvestigationalIt is a humanized immunoglobulin 2-alanine kappa antibody derived from two monoclonal antibodies (mAbs), an anti-BCMA mAb and an anti-CD3 mAb,[A261060] each of which contributes one heavy chain and one … [L47815] On August 14, 2023, the FDA granted accelerated approval to elranatamab for the treatment of multiple myeloma.
Synonyms: B-CELL MATURATION ANTIGEN (BCMA) CLUSTER OF DIFFERENTIATION 3 (CD3) BISPECIFIC MONOCLONAL ANTIBODY (MAB) ANTI-BCMA/ANTI-CD3 BISPECIFIC MAB, ANTI-CD3/ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY PF-06863135Peginterferon alfa-2a
go.drugbank.com/drugs/DB00008ApprovedInvestigational-2a for the treatment of Hepatitis C [A19593]. … Peginterferon alfa-2a is a form of recombinant interferon used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV).
Categories: Treatments for Hepatitis C, Cytochrome P-450 CYP1A2 InhibitorsProducts: PEGASYS PRE-FILLED SYRINGE FOR INJECTION 180 mcg/0.5 ml, PEGASYS PRE-FILLED SYRINGE FOR INJECTION 135 mcg/0.5 mlMethylnaltrexone
go.drugbank.com/drugs/DB06800ApprovedInvestigationalMethylnaltrexone is a pheriphally-acting μ-opioid antagonist that acts on the gastrointestinal tract to decrease opioid-induced constipation without producing analgesic effects or withdrawal symptoms. It is also a weak CYP2D6 inhibitor. ...
Categories: Drugs for Constipation, Peripheral Opioid Receptor AntagonistsProducts: Relistor Solution For Injection 12mg/0.6mLXimelagatran
go.drugbank.com/drugs/DB04898ApprovedWithdrawnXimelagatran is an anticoagulant intended to become a replacement for warfarin by overcoming the dietary restrictions, drug interaction, and monitoring issues associated with the former.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesNusinersen
go.drugbank.com/drugs/DB13161ApprovedInvestigationalAn antisense oligonucleotide that induces survival motor neuron (SMN) protein expression, it was approved by the U.S. … FDA in December, 2016 as Spinraza for the treatment of children and adults with spinal muscular atrophy (SMA). It is adminstrated as direct intrathecal injection.
Products: Spinraza 12 mg Solution for Injection